According to the British newspaper The Telegraph, the scientists behind the Oxford/AstraZeneca COVID-19 vaccine ... Click on 'follow', next to our logo above.

AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in ...

In a report released today, James Gordon from J.P. Morgan maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target ...

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

In a speech earlier this week which named AstraZeneca, the chancellor said life sciences would be key to boosting the economy. She announced plans to deliver an Oxford-Cambridge growth corridor ...

AstraZeneca became particularly prominent during the coronavirus pandemic, when it partnered with Oxford University to create one of the vaccines. Get the latest news and more great videos at ...

Britain on Monday hit back at AstraZeneca over the collapse of a 450 million pound ($558.5 million) investment, saying the drugmaker had scaled back the research and development portion of its plans, ...

BRITISH pharmaceutical giant AstraZeneca said on Friday (Jan 31 ... as well as backing several investment projects to make the Oxford-Cambridge axis a “European Silicon Valley”. Having already stalled ...

In substance and timing, AstraZeneca's decision to cancel a planned expansion of its flu vaccine facility at Speke is a blow to the government's recent zeal for growth. Instead of injecting £450m ...